SubQ: A Simpler, Less Disruptive Path to Lung Cancer Treatment

What if "one more medication" didn't have to feel like another punch? Host James Hiter sits down with ALK+ lung cancer survivor and patient advocate Stephanie Williams to demystify subcutaneous (SubQ) treatment delivery. Diagnosed at 37 with stage 2 non-small cell lung cancer, Stephanie brings both her patient experience and her background as a registered nurse to this conversation. She explains what SubQ delivery is, how it compares to traditional IV infusion, what to expect during an injection, and why this option can mean less anxiety, fewer infection risks, and more time back with family. You'll also hear Stephanie's clear, compassionate advice for the newly diagnosed: get biomarker testing, seek a second opinion, and connect with others who've walked this road. Whether you're a patient, caregiver, or simply curious about how lung cancer treatment is evolving, this episode offers practical insight and a hopeful look at where care is headed. Guests: Stephanie Williams, Patient Advocate, LCFA's Speakers Bureau Host: James Hiter, Patient Advocate, LCFA Board Member   READY TO TALK TO YOUR DOCTOR ABOUT SubQ? Download LCFA's free SubQ Conversation Toolkit — it includes a Treatment Delivery FAQ, a SubQ vs. IV infographic, and a Conversation Guide built specifically for your next appointment. Bring it with you and start the conversation with confidence. Get your free toolkit at: https://lcfamerica.org/about-lung-cancer/treatment/subcutaneous-delivery/  Transcript Link: https://lcfamerica.org/wp-content/uploads/2026/05/LCFA-AMA-SubQ-Simpler-Way-Transcript.pdf  Show Notes Link: https://lcfamerica.org/wp-content/uploads/2026/05/LCFA-AMA-SubQ-Simpler-Way-Show-Notes.pdf   Video: https://youtu.be/8UgbxAmuY0U